Kasiani C Myers

Summary

Affiliation: Cincinnati Children's Hospital Medical Center
Country: USA

Publications

  1. ncbi request reprint High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center and University of Cincinnati, OH 45229, USA
    Biol Blood Marrow Transplant 19:500-3. 2013
  2. doi request reprint Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, MLC 7015, Cincinnati, OH 45229, USA
    Hematol Oncol Clin North Am 27:117-28, ix. 2013
  3. doi request reprint Impaired immune function in children with Fanconi anaemia
    Kasiani C Myers
    Divisions of Bone Marrow Transplant and Immune Deficiency, Department of Pediatrics, Cincinnati Children s Hospital and Medical Center, Cincinnati, OH 45229, USA
    Br J Haematol 154:234-40. 2011
  4. doi request reprint The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations
    Kasiani Myers
    Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Pediatr Blood Cancer 58:462-5. 2012
  5. doi request reprint Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center and University of Cincinnati, Cincinnati, OH, USA
    J Pediatr 162:1235-40, 1240.e1. 2013
  6. ncbi request reprint Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, Cincinnati, OH
    J Pediatr 164:866-70. 2014
  7. doi request reprint Endocrine phenotype of children and adults with Fanconi anemia
    Susan R Rose
    Division of Endocrinology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 59:690-6. 2012
  8. doi request reprint An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis
    Rebecca A Marsh
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio Electronic address
    Biol Blood Marrow Transplant 19:1625-31. 2013
  9. doi request reprint Hematopoietic stem cell transplantation for bone marrow failure syndromes in children
    Kasiani C Myers
    Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, USA
    Biol Blood Marrow Transplant 15:279-92. 2009
  10. pmc The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters
    Wei Du
    Divisions of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, USA
    Blood 119:4142-51. 2012

Detail Information

Publications10

  1. ncbi request reprint High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center and University of Cincinnati, OH 45229, USA
    Biol Blood Marrow Transplant 19:500-3. 2013
    ..We conclude that high-dose steroid therapy if initiated early may reverse VOD of the liver in pediatric HSCT patients, abrogating the need for defibrotide therapy with its associated toxicities and regulatory difficulties...
  2. doi request reprint Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, MLC 7015, Cincinnati, OH 45229, USA
    Hematol Oncol Clin North Am 27:117-28, ix. 2013
    ..This article summarizes the clinical phenotype of SDS, diagnostic and treatment approaches, and novel advances in our understanding of the molecular pathophysiology of this disease...
  3. doi request reprint Impaired immune function in children with Fanconi anaemia
    Kasiani C Myers
    Divisions of Bone Marrow Transplant and Immune Deficiency, Department of Pediatrics, Cincinnati Children s Hospital and Medical Center, Cincinnati, OH 45229, USA
    Br J Haematol 154:234-40. 2011
    ..These findings may be especially relevant in this patient population with known predisposition to DNA damage and malignancy...
  4. doi request reprint The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations
    Kasiani Myers
    Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Pediatr Blood Cancer 58:462-5. 2012
    ....
  5. doi request reprint Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center and University of Cincinnati, Cincinnati, OH, USA
    J Pediatr 162:1235-40, 1240.e1. 2013
    ..To characterize the endocrine phenotype of patients with Shwachman-Diamond syndrome (SDS)...
  6. ncbi request reprint Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry
    Kasiani C Myers
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, Cincinnati, OH
    J Pediatr 164:866-70. 2014
    ..To investigate the range of clinical presentations for Shwachman-Diamond syndrome (SDS) with the long-term goal of improving diagnosis...
  7. doi request reprint Endocrine phenotype of children and adults with Fanconi anemia
    Susan R Rose
    Division of Endocrinology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229, USA
    Pediatr Blood Cancer 59:690-6. 2012
    ..We sought to further characterize the endocrine phenotype in children and adults with FA...
  8. doi request reprint An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis
    Rebecca A Marsh
    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio Electronic address
    Biol Blood Marrow Transplant 19:1625-31. 2013
    ..02). Our findings indicate that intermediate RIC reduces the incidence of mixed chimerism, is associated with a low incidence of upfront acute GVHD, and decreases the need for additional hematopoietic cell products after HCT. ..
  9. doi request reprint Hematopoietic stem cell transplantation for bone marrow failure syndromes in children
    Kasiani C Myers
    Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, USA
    Biol Blood Marrow Transplant 15:279-92. 2009
    ....
  10. pmc The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters
    Wei Du
    Divisions of Experimental Hematology and Cancer Biology, Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, USA
    Blood 119:4142-51. 2012
    ..In addition, oxidative stress-induced FANCD2 ubiquitination is required for the formation of a FA-BRG1-promoter complex. Taken together, these data identify a role for the FA pathway in cellular antioxidant defense...